Biggest News Aggregation in the World
📰 Term Extension News

Page 46 - Term Extension News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Term Extension. Real-time updates on events, politics, business and more.

FDA Approves Dermavant's VTAMA (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years

- EFFICACY: In the pivotal Phase 3 clinical trial program, VTAMA cream met all primary and secondary endpoints and demonstrated highly statistically significant improvement versus vehicle in Physician
New York United States Laurence Watts Kostenloser Wertpapierhandel Mark Lebwohl Angela Salerno Robin

Werner Luginbühl: «Könnten bereits 2025 Probleme mit dem Strom bekommen»

Werner Luginbühl: «Könnten bereits 2025 Probleme mit dem Strom bekommen» Elcom-Chef Luginbühl warnt: «Wir könnten bereits 2025 Probleme mit dem Strom bekommen» Die Aufsichtsbehörde Elcom warnt: Bereits 2025 könnte die Schweiz Stromversorgungsprobleme bekommen. Um Strom zu sparen, fordert die Behörde jetzt ein Impulsprogramm, damit die Schweizer ihre Elektroheizungen rasch ersetzen. Lucien Fluri / ch media Bild: KEYSTONE/TI-PRESS Werner Luginbühl (63) macht sich Sorgen um die Schweiz...
Department It They Parliament Power Companies Council Werner Energy Sources Nuclear Power Plants
Source: watson.ch

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Kampf gegen Krsko - Bundespräsident auf Anti-Atom-Kurs

(Bild: GLOBAL 2000 / Christopher Glanzl) Unterstützung im Kampf gegen den Hochrisiko-Nuklearreaktor Krško kommt jetzt von allerhöchster Stelle: Bundespräsident Alexander Van der Bellen begab sich Freitag bei einem Besuch bei unseren Kärntner Nachbarn auf ökologische Mission: „Es gibt keine sicheren Atomkraftwerke!“ Artikel teilen Drucken Selbstfahrende Elektro-Shuttles, smarte Straßenlaternen und Drohnen im Umwelteinsatz: Bundespräsident Alexander Van der Bellen machte sich ein Bild...
Nuclear Power Plants Carinthian National Captain Emperor Safety In Mind Continued Operation Term Extension Austrian Federal Government
Source: krone.at

Pfizer reports strong first-quarter 2021 results

Following the completion of the spin-off of the Upjohn Business (4) in the fourth quarter of 2020, Pfizer now operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products worldwide. Revenues and expenses associated with the Upjohn Business (4) for first-quarter 2020 have been recategorized as discontinued operations and excluded from Adjusted (2) results. Pfizer’s Meridian subsi...
South Africa South African Frank Damelio Mylannv Mylan Vyndaqel Vyndamax Albert Bourla

Somalia MPs revoke decision to extend Farmaajo's term by two years

THE STANDARD AFRICA By Reuters | May 1st 2021 Somalias President Mohamed Abdullahi Mohamed arrives for the swearing-in ceremony of Cyril Ramaphosa at Loftus Versfeld Stadium in Pretoria, South Africa in May 2019. [File] Somalias lower house of parliament voted unanimously on Saturday to cancel a divisive two-year presidential term extension it approved last month, a move that might help end an armed stand-off in the capital Mogadishu. The crisis over the term extension has raised fears that al ...
Nairobi Area Mohamed Abdullahi Mohamed Hussein Roble Abdirahman Odowaa Duale Hussein Rashid Abdi

LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021

LEO Pharma LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021 Monday, April 26, 2021 1:00PM IST (7:30AM GMT)   Ballerup, Denmark & Madison, N.J., United States:    Interim analysis at 56 weeks from ECZTEND, an open-label extension trial, demonstrates sustainable and durable efficacy of tralokinumab in adult patients 1 Patients enrolled in ECZTRA...
United States Linda Mayer Andrew Blauvelt Oregon Medical Research Center Global Research European Medicines Agency On

Redirecting to LEO Pharma Presents Long-Term Safety and Efficacy Data for Tralokinumab in Adults With Moderate-to-Severe Atopic Dermatitis at AAD VMX 2021

2.0 (2.4) Participants included 1,174 patients from ECZTEND at data cut-off.1 Observed outcomes for all patients enrolled 60 weeks prior to data cut-off (n=513) were analyzed at Week 56.1 At parent-trial baseline, ECZTEND baseline, and Week 56, median EASI score was 26.6, 4.7, and 1.8, respectively.1 At Week 56, IGA and EASI response rates were 49.7% (IGA 0/1), 95.1% (EASI-50), 82.8% (EASI-75), 61.0% (EASI-90), and 79.7% (EASI ≤7). An EASI score of ≤7 corresponds to mild atopic dermatitis.1...
United States Andrew Blauvelt Oregon Medical Research Center American Academy Of Dermatology Virtual Meeting Experience Global Research National Library Of Medicine

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science